欧洲抗体发现市场预测至 2030 年 - 区域分析 - 按抗体类型(单克隆抗体、多克隆抗体及其他)、性质(人类和人源化、嵌合和鼠类)、服务(噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示)和最终用户(制药和生物技术公司、研究实验室等)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 94    |    Report Code: BMIRE00030736    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Antibody Discovery Market
2022 年欧洲抗体发现市场价值为 8244.4111 亿美元,预计到 2030 年将达到 13294.8160 亿美元;预计 2022 年至 2030 年的复合年增长率为 6.2%。

癌症发病率上升推动欧洲抗体发现市场

根据 2020 年发布的全球癌症观察站 (GLOBOCAN) 估计,全球有 1930 万例癌症病例。到 2030 年 1 月,癌症幸存者的数量预计将达到 2210 万,这主要与人口老龄化有关。肺癌、乳腺癌、结直肠癌、前列腺癌和乳腺癌是报告最常见的癌症类型。癌症发病率的上升引起了全世界的关注。以下是 2020 年全球报告的常见癌症病例列表。

2020 年全球新癌症病例

Sr.序号

癌症类型

病例数(百万)

1

胃癌

1.09

2

皮肤癌(非黑色素瘤)

1.2

3

前列腺癌

1.41

4

结肠和直肠癌

1.93

5

肺癌

2.21

6

乳腺癌

2.26

资料来源:世界卫生组织,2020年2月

癌症现在是一种生活方式疾病,常见于饮食习惯不健康或不经常进行体育锻炼的人群。经常饮酒和吸烟会增加患癌症的风险。中低收入国家的慢性传染病会进一步加剧癌症风险因素。癌症发病率的上升表明需要创新的癌症治疗方法。单克隆抗体是一类有前途的靶向抗癌剂,可增强免疫系统抑制癌细胞活性和消除癌细胞的自然能力。抗体-药物偶联物 (ADC) 在癌症治疗中也显示出有希望的结果。此外,现代生物技术的进步使研究人员和公司能够提供精心设计的新型抗体,为成功治疗各种类型的癌症铺平了道路。因此,不同类型癌症发病率的迅速增长推动了抗体发现市场的增长。

欧洲抗体发现市场概况

欧洲抗体发现市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。该地区在全球市场中占有相当大的份额。由于单克隆抗体在研发应用、癌症治疗和免疫疾病管理中的使用激增,预计未来几年将实现强劲增长率。此外,对患者数据管理系统的不断增长的需求、慢性病的流行以及政府为实施抗体服务而采取的举措,预计将为法国、意大利和西班牙等国家的抗体发现市场提供增长机会。

欧洲抗体发现市场收入和预测到 2030 年(十亿美元)

欧洲抗体发现市场细分

欧洲抗体发现市场分为抗体类型、性质、服务、最终用户和国家。

根据抗体类型,欧洲抗体发现市场细分为单克隆抗体、多克隆抗体和其他。单克隆抗体部分在 2022 年占据了欧洲抗体发现市场的最大份额。

就性质而言,欧洲抗体发现市场细分为人类和人源化、嵌合和鼠类。人类和人源化部分在 2022 年占据了欧洲抗体发现市场的最大份额。

按服务,欧洲抗体发现市场分为噬菌体展示、杂交瘤、转基因动物、单细胞和酵母展示。噬菌体展示部分在 2022 年占据了欧洲抗体发现市场的最大份额。

根据最终用户,欧洲抗体发现市场分为制药和生物技术公司、研究实验室等。制药和生物技术公司部门在 2022 年占据了欧洲抗体发现市场的最大份额。

根据国家/地区,欧洲抗体发现市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。德国在 2022 年占据了欧洲抗体发现市场的主导地位。

Charles River Laboratories International Inc、Creative Biolabs Inc、Evotec SE、Sartorius AG、Aragen Life Sciences Ltd、Twist Bioscience Corp 和 Biocytogen Pharmaceuticals Beijing Co Ltd. 是欧洲抗体发现市场的一些领先公司。

Europe Antibody Discovery Strategic Insights

Strategic insights for Europe Antibody Discovery involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-antibody-discovery-market-strategic-framework.webp
Get more information on this report

Europe Antibody Discovery Report Scope

Report Attribute Details
Market size in 2022 US$ 8,24,441.11 Million
Market Size by 2030 US$ 13,29,481.60 Million
Global CAGR (2022 - 2030) 6.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 抗体类型
  • 单克隆抗体
  • 多克隆抗体
By 自然
  • 人类和人源化
  • 嵌合
  • é¼ ç±»
By 最终用户
  • 制药和生物技术公司
  • 研究实验室
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Get more information on this report

    Europe Antibody Discovery Regional Insights

    The regional scope of Europe Antibody Discovery refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-antibody-discovery-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Antibody Discovery Market

    1. Charles River Laboratories International Inc
    2. Creative Biolabs Inc
    3. Evotec SE
    4. Sartorius AG
    5. Aragen Life Sciences Ltd
    6. Twist Bioscience Corp
    7. Biocytogen Pharmaceuticals Beijing Co Ltd
    Frequently Asked Questions
    How big is the Europe Antibody Discovery Market?

    The Europe Antibody Discovery Market is valued at US$ 8,24,441.11 Million in 2022, it is projected to reach US$ 13,29,481.60 Million by 2030.

    What is the CAGR for Europe Antibody Discovery Market by (2022 - 2030)?

    As per our report Europe Antibody Discovery Market, the market size is valued at US$ 8,24,441.11 Million in 2022, projecting it to reach US$ 13,29,481.60 Million by 2030. This translates to a CAGR of approximately 6.2% during the forecast period.

    What segments are covered in this report?

    The Europe Antibody Discovery Market report typically cover these key segments-

  • 抗体类型 (单克隆抗体, 多克隆抗体)
  • 自然 (人类和人源化, 嵌合, 鼠类)
  • 最终用户 (制药和生物技术公司, 研究实验室)
  • What is the historic period, base year, and forecast period taken for Europe Antibody Discovery Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Antibody Discovery Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Europe Antibody Discovery Market?

    The Europe Antibody Discovery Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Charles River Laboratories International Inc
  • Creative Biolabs Inc
  • Evotec SE
  • Sartorius AG
  • Aragen Life Sciences Ltd
  • Twist Bioscience Corp
  • Biocytogen Pharmaceuticals Beijing Co Ltd
  • Who should buy this report?

    The Europe Antibody Discovery Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Antibody Discovery Market value chain can benefit from the information contained in a comprehensive market report.